NTRA Natera, Inc. $32.96B $238.81 BIIB Biogen Inc. $26.71B $182.09 INCY Incyte Corporation $20.51B $104.46 ILMN Illumina, Inc. $20.09B $131.45 GH Guardant Health, Inc. $13.46B $108.42 TEM Tempus AI, Inc. $13.40B $78.16 MRNA Moderna, Inc. $10.15B $25.98 GRAL GRAIL, Inc. $3.86B $110.39 ADPT Adaptive Biotechnologies Corporation $3.00B $19.66 TXG 10x Genomics, Inc. $2.32B $18.82 TWST Twist Bioscience Corporation $1.91B $32.01 MAZE Maze Therapeutics, Inc. $1.82B $37.75 RLAY Relay Therapeutics, Inc. $1.37B $7.92 PGEN Precigen, Inc. $1.15B $3.83 PSNL Personalis, Inc. $952.82M $10.73 NTLA Intellia Therapeutics, Inc. $942.03M $8.99 FLGT Fulgent Genetics, Inc. $907.97M $29.58 MYGN Myriad Genetics, Inc. $711.16M $7.63 PACB Pacific Biosciences of California, Inc. $695.90M $2.31 DSGN Design Therapeutics, Inc. $534.86M $9.39 DNA Ginkgo Bioworks Holdings, Inc. $507.12M $9.28 PEPG PepGen Inc. $443.02M $6.45 NEO NeoGenomics, Inc. $309.11M $12.10 FHTX Foghorn Therapeutics Inc. $268.61M $4.75 ARCT Arcturus Therapeutics Holdings Inc. $184.19M $6.79 CAMP CAMP4 Therapeutics Corporation $80.71M $3.80 MGX Metagenomi, Inc. Common Stock $65.71M $1.75 BNGO Bionano Genomics, Inc. $6.07M $1.85